Ambrx Biopharma Inc (DELISTED) (AMAM:DL)
27.99
+0.01
(+0.04%)
USD |
NASDAQ |
Mar 06, 16:00
28.00
+0.01
(+0.04%)
After-Hours: 20:00
Ambrx Biopharma Enterprise Value: 1.542B for March 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| March 06, 2024 | 1.542B |
| March 05, 2024 | 1.542B |
| March 04, 2024 | 1.541B |
| March 01, 2024 | 1.542B |
| February 29, 2024 | 1.539B |
| February 28, 2024 | 1.539B |
| February 27, 2024 | 1.537B |
| February 26, 2024 | 1.539B |
| February 23, 2024 | 1.539B |
| February 22, 2024 | 1.539B |
| February 21, 2024 | 1.524B |
| February 20, 2024 | 1.527B |
| February 16, 2024 | 1.528B |
| February 15, 2024 | 1.527B |
| February 14, 2024 | 1.528B |
| February 13, 2024 | 1.528B |
| February 12, 2024 | 1.530B |
| February 09, 2024 | 1.530B |
| February 08, 2024 | 1.530B |
| February 07, 2024 | 1.530B |
| February 06, 2024 | 1.529B |
| February 05, 2024 | 1.529B |
| February 02, 2024 | 1.530B |
| February 01, 2024 | 1.529B |
| January 31, 2024 | 1.530B |
| Date | Value |
|---|---|
| January 30, 2024 | 1.530B |
| January 29, 2024 | 1.530B |
| January 26, 2024 | 1.528B |
| January 25, 2024 | 1.528B |
| January 24, 2024 | 1.521B |
| January 23, 2024 | 1.527B |
| January 22, 2024 | 1.530B |
| January 19, 2024 | 1.521B |
| January 18, 2024 | 1.517B |
| January 17, 2024 | 1.517B |
| January 16, 2024 | 1.523B |
| January 12, 2024 | 1.541B |
| January 11, 2024 | 1.549B |
| January 10, 2024 | 1.537B |
| January 09, 2024 | 1.515B |
| January 08, 2024 | 1.509B |
| January 05, 2024 | 635.48M |
| January 04, 2024 | 618.42M |
| January 03, 2024 | 632.95M |
| January 02, 2024 | 629.79M |
| December 29, 2023 | 674.00M |
| December 28, 2023 | 690.42M |
| December 27, 2023 | 703.05M |
| December 26, 2023 | 692.94M |
| December 22, 2023 | 676.52M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.0853M
Minimum
Dec 08 2022
6.940B
Maximum
Jul 05 2023
2.229B
Average
1.515B
Median
Jan 09 2024
Enterprise Value Benchmarks
| Johnson & Johnson | 365.41B |
| Axonics Inc | 3.118B |
| Harpoon Therapeutics Inc (DELISTED) | 460.74M |
| Merck & Co Inc | 359.75B |
| RayzeBio inc (DELISTED) | 3.204B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -22.99M |
| Revenue (Quarterly) | 0.053M |
| Total Expenses (Quarterly) | 25.68M |
| EPS Diluted (Quarterly) | -0.37 |
| Profit Margin (Quarterly) | -43.38K% |
| Earnings Yield | -1.82% |
| Normalized Earnings Yield | -1.846 |